Product image of Memantine Clonmel (Memantine Hydrochloride) supplied by GNH India

Memantine Clonmel

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantine Clonmel (Memantine Hydrochloride)

Memantine Hydrochloride, the active ingredient in Memantine Clonmel, is an NMDA receptor antagonist presented as an oral formulation for oral use. It is used to treat moderate to severe Alzheimer’s disease in adults and may help maintain daily functional abilities while supporting cognitive performance.

GNH India supplies Memantine Clonmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with reliable quality assurance and regulatory compliance. Our distribution network ensures timely delivery across Europe, Asia, Africa and the Americas, adhering to local import requirements and cold‑chain standards where applicable.

Manufacturer / TM Owner

Clonmel Healthcare Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantine is indicated for Alzheimer’s disease, a neurodegenerative disorder affecting cognition and function.

  • Alzheimer's disease (moderate to severe): improves cognition and daily functional abilities.
  • Alzheimer's disease (behavioral symptoms): may reduce agitation and aggression in patients.
  • Alzheimer's disease (memory decline): may slow the rate of memory loss progression.
  • Alzheimer's disease (global function): supports overall neurological function and daily living activities.
  • Alzheimer's disease (caregiver support): may help maintain patient independence, easing caregiver burden.

How It Works

  • Memantine Hydrochloride acts as a non‑competitive antagonist at the N‑methyl‑D‑aspartate (NMDA) receptor. By binding to the receptor‑associated ion channel, it reduces excessive calcium influx caused by overstimulation with glutamate, thereby decreasing excitotoxic neuronal injury. This modulation of glutamatergic transmission helps preserve synaptic function and slows neurodegeneration associated with Alzheimer’s disease. The drug’s voltage‑dependent blocking action preferentially targets pathologically activated receptors while sparing normal synaptic activity, contributing to its therapeutic profile.

Side Effects

Memantine may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects

  • Dizziness
  • Headache
  • Constipation
  • Fatigue

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis)
  • Seizures
  • Hallucinations or psychosis

Precautions & Warnings

When prescribing memantine, clinicians should consider the following precautions to ensure safe use.

  • Renal impairment: adjust dose or monitor renal function in patients with reduced kidney function.
  • Hepatic disease: use caution in patients with liver dysfunction and monitor liver enzymes.
  • Cardiovascular conditions: assess for potential blood pressure changes in patients with unstable cardiovascular disease.
  • Concomitant CNS disorders: monitor for increased confusion or sedation in patients with existing central nervous system disorders.
  • Pregnancy and lactation: avoid use unless potential benefit justifies potential risk, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Avoid Interactions

Memantine can interact with other medicines; interactions are classified by their clinical significance.

Major Interactions (Avoid)

  • Amantadine: combined use may increase risk of neuropsychiatric adverse effects.
  • NMDA agonists (e.g., D‑cycloserine): may reduce memantine’s therapeutic effect.
  • High-dose vitamin D supplements: may potentiate hypercalcemia risk.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: additive cognitive impairment may occur.
  • CNS depressants (e.g., benzodiazepines): may enhance sedation and dizziness.
  • Diuretics (e.g., furosemide): monitor electrolytes as memantine may affect renal clearance.

Frequently Asked Questions

Memantine Clonmel contains memantine hydrochloride, which is prescribed for the treatment of moderate to severe Alzheimer’s disease. It helps improve cognitive function, daily living activities, and may reduce behavioral symptoms associated with the disease.

Memantine Hydrochloride works by non‑competitively blocking NMDA receptors in the brain. This reduces excessive calcium influx caused by glutamate over‑activation, limiting excitotoxic neuronal damage and supporting synaptic function in patients with Alzheimer’s disease.

The dose of Memantine Clonmel is determined by the prescribing clinician based on the patient’s condition, age, renal function and tolerability. Typical regimens involve a titration schedule, but the exact amount and frequency must be set by a qualified health professional.

Safety data for memantine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a healthcare provider.

To order Memantine Clonmel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents include acetylcholinesterase inhibitors such as donepezil. Memantine is typically used for moderate to severe disease and works by reducing excitotoxicity, while acetylcholinesterase inhibitors enhance cholinergic transmission. Both classes may be combined for additive benefit in some patients.

Memantine Clonmel should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources. Do not use if the packaging is damaged or the tablet appears discoloured.

Memantine is administered orally, usually as a tablet taken with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, seizures, and neuropsychiatric events like hallucinations or psychosis. Patients should be monitored for these events, especially during dose escalation or when combined with other CNS‑active drugs.

Memantine is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled cardiovascular disease, or those taking interacting medications that may increase neuropsychiatric side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT